Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Christian Behrenbruch

CEO at Telix Pharmaceuticals Ltd (TLX)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-7.4%
vs. S&P 500-12.8%
Beat the market0%
Paper profit on buys−$235K
Total bought / sold$997K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 6SEC TLXTelix Pharmaceuticals Ltd Buy 34,50020,709,500 held (+0%) $14.48 $500K -22.6%
May 6SEC TLXTelix Pharmaceuticals Ltd Buy 33,43520,742,935 held (+0%) $14.87 $497K -24.6%
  • Buy

    CEO Christian Behrenbruch bought $500K of TLX at $14.48 — first open-market purchase in our records.